Collaborative Indirect Treatment Comparisons with Multiple Distributed Single-arm Trials
多个分布式单臂试验的协作间接治疗比较
When randomized controlled trials are impractical or unethical to simultaneously compare multiple treatments, indirect treatment comparisons using single-arm trials offer valuable evidence for health technology assessments, especially for rare diseases and early-phase drug development. In practice, each sponsor conducts a single-arm trial on its own drug with restricted data-sharing and targets effects in its trial population, which can lead to unfair comparisons. This…